Cowealth Medical China (603122.SH): 219 million restricted shares will be listed for trading starting from February 17, accounting for 55% of the total share capital.
Guofu China (603122.SH) announced that the restricted shares for this listing are the shares initially issued by the company for the first time.
Cowealth Medical China (603122.SH) announced that the restricted shares to be listed this time are part of the company's first public offering of restricted shares. The restricted period is 36 months from the date the company's shares are listed, totaling 219 million shares, accounting for 55% of the company's total share capital, involving only one shareholder, Heifu (Hong Kong) Holdings Limited. The lock-up period is about to expire, and the above-mentioned restricted shares will be listed and tradable starting from February 17, 2025.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


